The balance between these AT- derived factors, the adiponectin/leptin (Adpn/Lep) ratio, has been proposed as a reliable biomarker of the AT dysfunction and inflammation, corresponding more closely with insulin resistance than adiponectin and leptin separately and decreasing with the augmented number of metabolic risk factors [16,17]. The gene discussed is ADIPOQ; the disease is Insulin resistance.